MicroRNA Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global MicroRNA Market By Type (MicroRNA Arrays, Next Gen Sequencing, Immunoassay, PCR-Based Assay) By Application (Research and development, Clinical diagnostics) By End-user (Research and Academic Institutes, Biopharmaceutical Companies, Diagnostic Centers ), By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

The global microRNA market size valued USD 864.2 million in 2020 and expected to grow at a CAGR of 18.6% during the forecast period 2021-2027. A microRNA is a single-stranded RNA molecule that can be found in animals, plants and viruses. Two of the most important functions of miRNAs are post-transcriptional control of gene expression and RNA silencing. MiRNAs work in tandem with messenger RNA (mRNA) to suppress gene expression and regulate a variety of biological activities including cell differentiation, proliferation, and death. They are involved in cell physiology and development, as well as pathological processes such as viral infections, autoimmune disorders, and carcinogenesis, in addition to detecting different cell types. MiRNAs can be found in great quantities in a variety of mammalian cell types.

MicroRNA Market

MARKET SUMMARY
-
18.6% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 18.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

MicroRNA Market

  • The report on global microRNA market gives historical, current and future market sizes (US$ Mn) based on application, type, end user and geographical regions.
  • microRNA market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Illumina, Inc.
  • GE Healthcare
  • Agilent Technologies
MicroRNA Market

Drivers And Restraints

Growing incidence and prevalence of cancer and cardiovascular diseases is the major driving factor for growth of the MicroRNA market. As per GLOBOCON statistics, around 1, 604 cancer cases per 100,000 people were reported globally in 2012. Furthermore, increase in demand for bioinformatics, rise in usage and demand for advanced technologies, growing R&D investments by market players are expected to propel the growth of MicroRNA market. However, high cost associated with MicroRNA’s, lack of awareness, unfavourable regulatory framework is expected to dampen the Global MicroRNA market.


North-America got significant share

MicroRNA Market

Geographically Global Market is segmented as Latin America, North America, Asia Pacific, The Middle East and Africa and Europe. North America holds the largest position in global miRNA market owing to high prevalence of cancer, high adoption of advanced technology, availability of various reimbursement policies. According to American Cancer society, in U.S. one in every four deaths is accounted by cancer. Asia pacific offers lucrative opportunities due to increase in chronic diseases prevalence, growing researches on development of miRNA’s, development in healthcare sector. For example, in May 2015, an algorithm and detection technology of miRNA for non-invasive diagnosis of cancer was developed by Researchers who belongs to National University of Singapore and Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In April 2014, Exigon launched high potent miRCURY LNA, a microRNA mimics for functional analysis.
  • In January 2014, HTG molecular Diagnostics launched an assay with nuclease protection probe technology that targets 2,275 miRNAs.

Key

Key Features of the Report

MicroRNA Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global MicroRNA Market Introduction
2.1. Global MicroRNA Market – Taxonomy
2.2. Global MicroRNA Market –Definitions
2.2.1. By Product
2.2.2. By Service
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global MicroRNA Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global MicroRNA Market Dynamic Factors – Impact Analysis
3.6. Global MicroRNA Market – Competition Landscape
4. Global MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global MicroRNA Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1.  Workflow
5.1.1.1. Whole Blood
5.1.1.1.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.1.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.1.3.  Market Opportunity Analysis
5.1.1.2. Serum
5.1.1.2.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.2.3.  Market Opportunity Analysis
5.1.1.3. Plasma
5.1.1.3.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.3.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3.3.  Market Opportunity Analysis
5.1.1.4. Isolation & Purification
5.1.1.4.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.4.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.4.3.  Market Opportunity Analysis
5.1.1.5. Fresh Frozen Tissue
5.1.1.5.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.5.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.5.3.  Market Opportunity Analysis
5.1.1.6. FFPE
5.1.1.6.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.6.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.6.3.  Market Opportunity Analysis
5.1.1.7. Others
5.1.1.7.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.7.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.7.3.  Market Opportunity Analysis
5.1.2. Technology
5.1.2.1. Microarray
5.1.2.1.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.1.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.1.3.  Market Opportunity Analysis
5.1.2.2. NGS
5.1.2.2.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.2.3.  Market Opportunity Analysis
5.1.2.3. Real Time PCR
5.1.2.3.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.3.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3.3.  Market Opportunity Analysis
5.1.2.4. Others
5.1.2.4.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.4.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.4.3.  Market Opportunity Analysis
5.1.3. Functional Analysis & Others
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. miRNA cDNA Synthesis
5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Profiling, Localization, & Quantification
5.1.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.1.6. Others
5.1.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.6.3. Market Opportunity Analysis
5.2. Consumables
5.2.1.  Specimen
5.2.1.1. FFPE
5.2.1.1.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.1.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.1.3.  Market Opportunity Analysis
5.2.1.2. Fresh Frozen Tissue
5.2.1.2.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.2.3.  Market Opportunity Analysis
5.2.1.3. Plasma
5.2.1.3.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.3.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3.3.  Market Opportunity Analysis
5.2.1.4. Serum
5.2.1.4.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.4.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.4.3.  Market Opportunity Analysis
5.2.1.5. Whole Blood
5.2.1.5.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.5.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.5.3.  Market Opportunity Analysis
5.2.1.6. Others
5.2.1.6.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.6.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.6.3.  Market Opportunity Analysis
5.2.2. Workflow
5.2.2.1. Functional Analysis
5.2.2.1.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.1.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.1.3.  Market Opportunity Analysis
5.2.2.2. Isolation & Purification
5.2.2.2.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.2.3.  Market Opportunity Analysis
5.2.2.3. miRNA cDNA Synthesis
5.2.2.3.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.3.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3.3.  Market Opportunity Analysis
5.2.2.4. Profiling, Localization, & Quantification
5.2.2.4.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.4.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.4.3.  Market Opportunity Analysis
5.2.2.5. Others
5.2.2.5.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.5.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.5.3.  Market Opportunity Analysis
6. Global MicroRNA Market, By Service, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Service Type
6.1.1. Profiling, Localization, & Quantification
6.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. miRNA cDNA Synthesis
6.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.1.3. Isolation & Purification
6.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3.3. Market Opportunity Analysis
6.1.4. Functional Analysis
6.1.4.1. Real Time PCR
6.1.4.1.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.4.1.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.1.3.  Market Opportunity Analysis
6.1.4.2. Microarray
6.1.4.2.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.4.2.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.2.3.  Market Opportunity Analysis
6.1.4.3. NGS
6.1.4.3.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.4.3.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.3.3.  Market Opportunity Analysis
6.1.4.4. Others
6.1.4.4.1.  Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.4.4.2.  Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.4.3.  Market Opportunity Analysis
6.1.5. Others
6.1.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.5.3. Market Opportunity Analysis
6.2. Specimen
6.2.1. FFPE
6.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.3. Market Opportunity Analysis
6.2.2. Fresh Frozen Tissue
6.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.3. Market Opportunity Analysis
6.2.3. Plasma
6.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3.3. Market Opportunity Analysis
6.2.4. Serum
6.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.4.3. Market Opportunity Analysis
6.2.5. Whole Blood
6.2.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.5.3. Market Opportunity Analysis
6.2.6. Others
6.2.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.6.3. Market Opportunity Analysis
7. Global MicroRNA Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Cardiovascular Disease
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Infectious Diseases
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Neurological Disease
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Immunological Disorder
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Cancer
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global MicroRNA Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Academic & Government Research Institutes
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Biotechnology & Pharmaceutical Companies
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Other end-users
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global MicroRNA Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Region, 2022-2028
10. North America MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.1.1. Workflow
10.1.1.1.1.              Whole Blood
10.1.1.1.2.              Serum
10.1.1.1.3.              Plasma
10.1.1.1.4.              Isolation & Purification
10.1.1.1.5.              Fresh Frozen Tissue
10.1.1.1.6.              FFPE
10.1.1.1.7.              Others
10.1.1.2. Technology
10.1.1.2.1.              Microarray
10.1.1.2.2.              NGS
10.1.1.2.3.              Real Time PCR
10.1.1.2.4.              Others
10.1.1.3. Functional Analysis & Others
10.1.1.4. miRNA cDNA Synthesis
10.1.1.5. Profiling, Localization, & Quantification
10.1.1.6. Others
10.1.2. Consumables
10.1.2.1. Specimen
10.1.2.1.1.              FFPE
10.1.2.1.2.              Fresh Frozen Tissue
10.1.2.1.3.              Plasma
10.1.2.1.4.              Serum
10.1.2.1.5.              Whole Blood
10.1.2.1.6.              Others
10.1.2.2. Workflow
10.1.2.2.1.              Functional Analysis
10.1.2.2.2.              Isolation & Purification
10.1.2.2.3.              miRNA cDNA Synthesis
10.1.2.2.4.              Profiling, Localization, & Quantification
10.1.2.2.5.              Others
10.2. Service Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Service Type
10.2.1.1. Profiling, Localization, & Quantification
10.2.1.2. miRNA cDNA Synthesis
10.2.1.3. Isolation & Purification
10.2.1.4. Functional Analysis
10.2.1.4.1.              Real Time PCR
10.2.1.4.2.              Microarray
10.2.1.4.3.              NGS
10.2.1.5. Others
10.2.1.4. Others
10.2.3. Specimen
10.2.3.1. FFPE
10.2.3.2. Fresh Frozen Tissue
10.2.3.3. Plasma
10.2.3.4. Serum
10.2.3.5. Whole Blood
10.2.3.6. Others
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cardiovascular Disease
10.3.2. Infectious Diseases
10.3.3. Neurological Disease
10.3.4. Immunological Disorder
10.3.5. Cancer
10.3.6. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Academic & Government Research Institutes
10.4.2. Biotechnology & Pharmaceutical Companies
10.4.3. Other end-users
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Country, 2022-2028
10.7. North America MicroRNA Market Dynamics – Trends
11. Europe MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.1.1. Workflow
11.1.1.1.1.              Whole Blood
11.1.1.1.2.              Serum
11.1.1.1.3.              Plasma
11.1.1.1.4.              Isolation & Purification
11.1.1.1.5.              Fresh Frozen Tissue
11.1.1.1.6.              FFPE
11.1.1.1.7.              Others
11.1.1.2. Technology
11.1.1.2.1.              Microarray
11.1.1.2.2.              NGS
11.1.1.2.3.              Real Time PCR
11.1.1.2.4.              Others
11.1.1.3. Functional Analysis & Others
11.1.1.4. miRNA cDNA Synthesis
11.1.1.5. Profiling, Localization, & Quantification
11.1.1.6. Others
11.1.2. Consumables
11.1.2.1. Specimen
11.1.2.1.1.              FFPE
11.1.2.1.2.              Fresh Frozen Tissue
11.1.2.1.3.              Plasma
11.1.2.1.4.              Serum
11.1.2.1.5.              Whole Blood
11.1.2.1.6.              Others
11.1.2.2. Workflow
11.1.2.2.1.              Functional Analysis
11.1.2.2.2.              Isolation & Purification
11.1.2.2.3.              miRNA cDNA Synthesis
11.1.2.2.4.              Profiling, Localization, & Quantification
11.1.2.2.5.              Others
11.2. Service Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Service Type
11.2.1.1. Profiling, Localization, & Quantification
11.2.1.2. miRNA cDNA Synthesis
11.2.1.3. Isolation & Purification
11.2.1.4. Functional Analysis
11.2.1.4.1.              Real Time PCR
11.2.1.4.2.              Microarray
11.2.1.4.3.              NGS
11.2.1.5. Others
11.2.1.6 Others
11.2.3. Specimen
11.2.3.1. FFPE
11.2.3.2. Fresh Frozen Tissue
11.2.3.3. Plasma
11.2.3.4. Serum
11.2.3.5. Whole Blood
11.2.3.6. Others
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cardiovascular Disease
11.3.2. Infectious Diseases
11.3.3. Neurological Disease
11.3.4. Immunological Disorder
11.3.5. Cancer
11.3.6. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Academic & Government Research Institutes
11.4.2. Biotechnology & Pharmaceutical Companies
11.4.3. Other end-users
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Country, 2022-2028
11.7. Europe MicroRNA Market Dynamics – Trends
12. Asia-Pacific MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.1.1. Workflow
12.1.1.1.1.              Whole Blood
12.1.1.1.2.              Serum
12.1.1.1.3.              Plasma
12.1.1.1.4.              Isolation & Purification
12.1.1.1.5.              Fresh Frozen Tissue
12.1.1.1.6.              FFPE
12.1.1.1.7.              Others
12.1.1.2. Technology
12.1.1.2.1.              Microarray
12.1.1.2.2.              NGS
12.1.1.2.3.              Real Time PCR
12.1.1.2.4.              Others
12.1.1.3. Functional Analysis & Others
12.1.1.4. miRNA cDNA Synthesis
12.1.1.5. Profiling, Localization, & Quantification
12.1.1.6. Others
12.1.2. Consumables
12.1.2.1. Specimen
12.1.2.1.1.              FFPE
12.1.2.1.2.              Fresh Frozen Tissue
12.1.2.1.3.              Plasma
12.1.2.1.4.              Serum
12.1.2.1.5.              Whole Blood
12.1.2.1.6.              Others
12.1.2.2. Workflow
12.1.2.2.1.              Functional Analysis
12.1.2.2.2.              Isolation & Purification
12.1.2.2.3.              miRNA cDNA Synthesis
12.1.2.2.4.              Profiling, Localization, & Quantification
12.1.2.2.5.              Others
12.2. Service Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Service Type
12.2.1.1. Profiling, Localization, & Quantification
12.2.1.2. miRNA cDNA Synthesis
12.2.1.3. Isolation & Purification
12.2.1.4. Functional Analysis
12.2.1.4.1.              Real Time PCR
12.2.1.4.2.              Microarray
12.2.1.4.3.              NGS
12.2.1.5. Others
12.2.1.6 Others
12.2.3. Specimen
12.2.3.1. FFPE
12.2.3.2. Fresh Frozen Tissue
12.2.3.3. Plasma
12.2.3.4. Serum
12.2.3.5. Whole Blood
12.2.3.6. Others
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cardiovascular Disease
12.3.2. Infectious Diseases
12.3.3. Neurological Disease
12.3.4. Immunological Disorder
12.3.5. Cancer
12.3.6. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Academic & Government Research Institutes
12.4.2. Biotechnology & Pharmaceutical Companies
12.4.3. Other end-users
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Country, 2022-2028
12.7. Asia-Pacific MicroRNA Market Dynamics – Trends
13. Latin America MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.1.1. Workflow
13.1.1.1.1.              Whole Blood
13.1.1.1.2.              Serum
13.1.1.1.3.              Plasma
13.1.1.1.4.              Isolation & Purification
13.1.1.1.5.              Fresh Frozen Tissue
13.1.1.1.6.              FFPE
13.1.1.1.7.              Others
13.1.1.2. Technology
13.1.1.2.1.              Microarray
13.1.1.2.2.              NGS
13.1.1.2.3.              Real Time PCR
13.1.1.2.4.              Others
13.1.1.3. Functional Analysis & Others
13.1.1.4. miRNA cDNA Synthesis
13.1.1.5. Profiling, Localization, & Quantification
13.1.1.6. Others
13.1.2. Consumables
13.1.2.1. Specimen
13.1.2.1.1.              FFPE
13.1.2.1.2.              Fresh Frozen Tissue
13.1.2.1.3.              Plasma
13.1.2.1.4.              Serum
13.1.2.1.5.              Whole Blood
13.1.2.1.6.              Others
13.1.2.2. Workflow
13.1.2.2.1.              Functional Analysis
13.1.2.2.2.              Isolation & Purification
13.1.2.2.3.              miRNA cDNA Synthesis
13.1.2.2.4.              Profiling, Localization, & Quantification
13.1.2.2.5.              Others
13.2. Service Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Service Type
13.2.1.1. Profiling, Localization, & Quantification
13.2.1.2. miRNA cDNA Synthesis
13.2.1.3. Isolation & Purification
13.2.1.4. Functional Analysis
13.2.1.4.1.              Real Time PCR
13.2.1.4.2.              Microarray
13.2.1.4.3.              NGS
13.2.1.5. Others
13.2.1.6 Others
13.2.3. Specimen
13.2.3.1. FFPE
13.2.3.2. Fresh Frozen Tissue
13.2.3.3. Plasma
13.2.3.4. Serum
13.2.3.5. Whole Blood
13.2.3.6. Others
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cardiovascular Disease
13.3.2. Infectious Diseases
13.3.3. Neurological Disease
13.3.4. Immunological Disorder
13.3.5. Cancer
13.3.6. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Academic & Government Research Institutes
13.4.2. Biotechnology & Pharmaceutical Companies
13.4.3. Other end-users
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Country, 2022-2028
13.7. Latin America MicroRNA Market Dynamics – Trends
14. Middle East and Africa MicroRNA Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.1.1. Workflow
14.1.1.1.1.              Whole Blood
14.1.1.1.2.              Serum
14.1.1.1.3.              Plasma
14.1.1.1.4.              Isolation & Purification
14.1.1.1.5.              Fresh Frozen Tissue
14.1.1.1.6.              FFPE
14.1.1.1.7.              Others
14.1.1.2. Technology
14.1.1.2.1.              Microarray
14.1.1.2.2.              NGS
14.1.1.2.3.              Real Time PCR
14.1.1.2.4.              Others
14.1.1.3. Functional Analysis & Others
14.1.1.4. miRNA cDNA Synthesis
14.1.1.5. Profiling, Localization, & Quantification
14.1.1.6. Others
14.1.2. Consumables
14.1.2.1. Specimen
14.1.2.1.1.              FFPE
14.1.2.1.2.              Fresh Frozen Tissue
14.1.2.1.3.              Plasma
14.1.2.1.4.              Serum
14.1.2.1.5.              Whole Blood
14.1.2.1.6.              Others
14.1.2.2. Workflow
14.1.2.2.1.              Functional Analysis
14.1.2.2.2.              Isolation & Purification
14.1.2.2.3.              miRNA cDNA Synthesis
14.1.2.2.4.              Profiling, Localization, & Quantification
14.1.2.2.5.              Others
14.2. Service Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Service Type
14.2.1.1. Profiling, Localization, & Quantification
14.2.1.2. miRNA cDNA Synthesis
14.2.1.3. Isolation & Purification
14.2.1.4. Functional Analysis
14.2.1.4.1.              Real Time PCR
14.2.1.4.2.              Microarray
14.2.1.4.3.              NGS
14.2.1.5. Others
14.2.1.6. Others
14.2.3. Specimen
14.2.3.1. FFPE
14.2.3.2. Fresh Frozen Tissue
14.2.3.3. Plasma
14.2.3.4. Serum
14.2.3.5. Whole Blood
14.2.3.6. Others
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cardiovascular Disease
14.3.2. Infectious Diseases
14.3.3. Neurological Disease
14.3.4. Immunological Disorder
14.3.5. Cancer
14.3.6. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Academic & Government Research Institutes
14.4.2. Biotechnology & Pharmaceutical Companies
14.4.3. Other end-users
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA MicroRNA Market – Opportunity Analysis Index, By Product, Service, Application, End User, and Country, 2022-2028
14.7. MEA MicroRNA Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. QIAGEN N.V. (Hilden, Germany)
15.2.2. Thermo Fisher Scientific (Waltham, U.S.)
15.2.3. BioVendor (Brno, Czech Republic)
15.2.4. Takara Bio Inc. (Shiga, Japan)
15.2.5. Merck KGaA (Darmstadt, Germany)
15.2.6. NanoString Technologies, Inc. (Washington, U.S.)
15.2.7. Heim Biotek (Seongnam, South Korea)
15.2.8. GeneCopoeia, Inc. (Maryland, U.S.)
15.2.9. Takara Bio Inc. (Shiga, Japan)
15.2.10. Sistemic Scotland Limited (United Kingdom)
16. Research Methodology
17. Key Assumptions and Acronyms


Report

Company Profile

  • Thermo Fisher Scientific Inc.(U.S.)
  • QIAGEN (Exiqon) (Germany)
  • Illumina, Inc. (U.S.)
  • GE Healthcare (UK)
  • Agilent Technologies (U.S.)
  • GeneCopoeia, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Promega Corporation (U.S.)
  • Merck & Co., Inc.(U.S.)

Description

The global microRNA market size valued USD 864.2 million in 2020 and expected to grow at a CAGR of 18.6% during the forecast period 2021-2027. A microRNA is a single-stranded RNA molecule that can be found in animals, plants and viruses. Two of the most important functions of miRNAs are post-transcriptional control of gene expression and RNA silencing. MiRNAs work in tandem with messenger RNA (mRNA) to suppress gene expression and regulate a variety of biological activities including cell differentiation, proliferation, and death. They are involved in cell physiology and development, as well as pathological processes such as viral infections, autoimmune disorders, and carcinogenesis, in addition to detecting different cell types. MiRNAs can be found in great quantities in a variety of mammalian cell types.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX